Skip to main content
Clinical Trials/NCT01874600
NCT01874600
Unknown
Not Applicable

A Pivotal, Phase III Trial of Detecting Generalized Tonic-Clonic Seizures With a Seizure Detection and Warning System in Epilepsy Patients

Brain Sentinel1 site in 1 country239 target enrollmentJuly 2013
ConditionsEpilepsy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Epilepsy
Sponsor
Brain Sentinel
Enrollment
239
Locations
1
Primary Endpoint
Primary outcome is accuracy of device to detect GTC seizures when compared to video EEG.
Last Updated
6 years ago

Overview

Brief Summary

The seizure detection and warning system is an ambulatory system designed to monitor and analyze EMG data to detect the onset of GTC seizures and to provide a warning signal to alert caregivers that a seizure is occurring.

Registry
clinicaltrials.gov
Start Date
July 2013
End Date
December 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subject has a suspected history of GTC seizures, either primary GTC or partial onset seizures with secondary generalization.
  • Is being admitted to a hospital for routine vEEG monitoring related to seizures.
  • Male or female between the ages of 13-
  • If female and of childbearing potential, has a negative pregnancy urine test, and must also not be nursing.
  • Can understand and sign written informed consent, or will have a parent or a legally authorized representative (LAR) who can do so, prior to the performance of any study assessments.
  • Subject and/or Primary Caregiver must be competent to follow all study procedures.
  • Is able to read, speak, and understand English or has a LAR that does so.
  • Subject/LAR consents to the use of vEEG files, including video/audio recordings, for purposes of this research study.

Exclusion Criteria

  • Has not had a GTC seizure within the last year AND is not expected to have a reduction of anti-epileptic drugs during their hospital admission.
  • Intracranial EEG electrodes are being used.
  • The subject is allergic to adhesives or any component of the electrode patch assembly

Outcomes

Primary Outcomes

Primary outcome is accuracy of device to detect GTC seizures when compared to video EEG.

Time Frame: less than 1 month

The primary objective of the research is to determine the ability of the Brain Sentinel Seizure Detection System to accurately detect GTC seizures in comparison to the recognized "gold standard" for seizure detection, video Electroencephalography (vEEG).The primary endpoint will be the sensitivity of GTC seizure detection (defined as within 30 seconds of motor manifestation via vEEG analysis) in a hospital setting.

Secondary Outcomes

  • Comparison of study device to self reporting of seizures using a seizure diary.(Less than 1 month)

Study Sites (1)

Loading locations...

Similar Trials